How Zovighian was paid
$17.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|---|---|
| Bernard ZovighianChief Executive Officer and Director | $1,192,500 | — | $7,167,024 | $6,499,109 | $2,406,537 | — | $189,085 | $17,454,255 |
| Scott B. UllemCorporate Vice President, Chief Financial Officer | $807,898 | — | $2,205,238 | $1,999,726 | $966,435 | — | $71,257 | $6,050,554 |
| Donald E. Bobo, Jr.Corporate Vice President, Strategy & Corporate Development | $759,783 | $4,000 | $1,378,274 | $1,249,829 | $786,899 | — | $48,580 | $4,223,365 |
| Annette BrülsCorporate Vice President, EMEACLA | $726,586 | — | $1,020,334 | $924,995 | $719,581 | $158,905 | $181,706 | $3,732,107 |
| Daveen ChopraCorporate Vice President, Transcatheter Mitral and Tricuspid Therapies | $671,042 | — | $1,764,066 | $1,375,784 | $824,239 | — | $60,611 | $4,695,742 |
| Larry L. WoodFormer Corporate Vice President and Group President | $635,919 | — | $1,818,499 | $1,648,710 | $689,382 | — | $61,829 | $4,854,339 |
What changed and why
- $17.5MCEO total compensation increased to $17,454,255 in 2025 from $14,579,474 in 2024.
- $6.1BCompany sales reached $6.1 billion, representing 11.5% underlying growth year-over-year.
- $1BResearch and development investments exceeded $1 billion during 2025.
- 127%Corporate annual incentive plan funded at 127% based on performance outcomes.
- 2022 performance-based restricted stock units were entirely forfeited for failing relative TSR thresholds.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.